As COVID-19 contagion rates climb across Europe, the United States, and Asia, health authorities report that new Omicron subvariants—including XFG, Nimbus, and Stratus—are driving a seasonal resurgence of the virus. While viral transmission has accelerated with the onset of autumn, public health agencies emphasize that the current epidemiological situation remains stable and non-emergent compared to previous pandemic years.
Global COVID-19 cases rise during colder weather
The recent increase in infections reflects a broader, global pattern of viral recrudescence typically observed during the transition into colder weather. The latest World Health Organization dashboard update reports 69,575 new cases worldwide for the period between August 10 and September 6, 2026, compared to 47,506 in the preceding 28 days, with increases exceeding 10 percent recorded in 30 countries across the Americas, Europe, and Southeast Asia. In France, the number of general practitioner visits for COVID-19 surged by 76 percent between September 14 and 20 compared to the previous week, according to data published by Santé publique France. Antoine Flahault, an epidemiologist and professor of public health at the University of Paris-Cité, noted in interviews with Paris Match that this upward trend spans Europe, the United States, and Asia, driven by highly transmissible variants that partially evade existing immune barriers.
In Italy, public health tracking mirrors this European trend. National health data recorded 128 new cases in a late-September bulletin, with Lombardy alone accounting for 74 of those diagnoses—more than half the national total. Despite this localized concentration, national incidence remains low, staying under one diagnosed case per 100,000 residents, while the overall increase in notified cases shows significant regional differences, with Lombardy recording the highest number of diagnoses and an incidence above the national average.
New Omicron Subvariants Under Close Scientific Monitoring
The virus continues to evolve through mutations in the Spike protein, allowing descendant strains to encounter fewer obstacles in individuals with pre-existing immunity from past infections or vaccinations. Surveillance data highlights the circulation of several Omicron derivatives, most notably XFG—also referred to as Stratus—and NB.1.8.1, known as Nimbus, another descendant of the JN.1 family that previously drew international attention in 2025 following its spread in several Asian countries. Both lineages originate from the JN.1 family and are currently classified by the World Health Organization (WHO) and the ECDC as variants under monitoring (VUM).
Neither the WHO nor the ECDC has classified these strains as variants of concern (VOC). According to European health agencies, current clinical evidence indicates no sign that XFG or Nimbus causes more severe disease than earlier Omicron iterations. Typical symptoms remain consistent with past variants, presenting primarily as fever, sore throat, cough, fatigue, and nasal congestion.
Europe needs independent industrial capacity for medicines
Addressing parliamentary inquiries regarding future health crises, General Francesco Figliuolo emphasized the necessity of structural autonomy within Europe during an audit by the parliamentary commission investigating pandemic management. Figliuolo pointed to antimicrobial resistance and zoonotic spillover as foreseeable risks, arguing that European nations must maintain independent industrial capacity for essential medicines and medical devices rather than relying entirely on external supply chains.
Public health institutions stress that while vulnerable populations—such as the elderly, immunocompromised individuals, and pregnant women—face higher risks of severe illness or complications, the general population experiences the current viral circulation much like seasonal influenza. Diagnostic tools, preventative measures, and medical treatments remain widely available to manage transmission as seasonal activities resume in schools and workplaces.
What are the primary symptoms of COVID-19 subvariants?
What are the primary symptoms associated with the current COVID-19 subvariants?
Symptoms linked to strains like XFG (Stratus) and NB.1.8.1 (Nimbus) closely mirror previous Omicron infections. Patients typically experience fever, cough, sore throat, fatigue, and nasal congestion without novel clinical presentations.
Are variants like XFG and Nimbus classified as dangerous new threats?
No. Both the ECDC and the WHO classify these lineages as variants under monitoring rather than variants of concern. Official data indicates no evidence of increased disease severity compared to earlier strains.
How much have infection rates grown in neighboring European countries?
In France, general practitioner visits for COVID-19 increased by 76 percent between September 14 and 20 compared to the preceding week, according to public health data.
Which Italian region has reported the highest number of recent cases?
Lombardy reported 74 new cases in late September, representing over half of the 128 total cases registered nationwide during that reporting period.
Worth a look